Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 23, 2021

Machine Learning Predicts Tamoxifen Nonadherence in MBC

JCO clinical cancer informatics


Additional Info

Disclosure statements are available on the authors' profiles:

JCO clinical cancer informatics
Machine Learning to Predict Tamoxifen Nonadherence Among US Commercially Insured Patients With Metastatic Breast Cancer
JCO Clin Cancer Inform 2021 Aug 01;5(1)814-825, G Yerrapragada, A Siadimas, A Babaeian, V Sharma, TJ O'Neill

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading